Explores how clinical monitoring is evolving from site-dependent reviews to risk-based, remote, and technology-driven oversight. COVID-19 accelerated adoption of centralized monitoring, predictive analytics, and AI/ML applications for real-time alerts and safety tracking. Regulators encourage reduced reliance on retrospective document checks in favor of continuous surveillance. Benefits include lower costs, faster detection of risks, and improved patient safety. The paper stresses scalable RBM solutions, cloud platforms, and automation as the future standard for clinical trial monitoring.

Join for free to read